Knowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis

References

• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–17. doi:10.1016/j.jacc.2020.11.010.
   PubMed Web of Science ®Google Scholar
• Ho FM, Liao YH, Yang AJ, Lee CP, Hou YC, Huang CT, Lin SR, Lee KR, Huang KC, Lin WW. Anti-atherosclerotic action of ger-gen-chyn-lian-tang and ampk-dependent lipid lowering effect in hepatocytes. J Ethnopharmacol. 2012;142(1):175–87. doi:10.1016/j.jep.2012.04.034.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–51. doi:10.1161/ATVBAHA.108.179705.
   PubMed Web of Science ®Google Scholar
• Taylor J. Viewpoint: the immune system and atherosclerosis. Circulation. 2006;114:f145–f6.
   PubMed Web of Science ®Google Scholar
• Stehbens WE. The role of hemodynamics in the pathogenesis of atherosclerosis. Prog Cardiovasc Dis. 1975;18(1):89–103. doi:10.1016/0033-0620(75)90009-2.
   PubMed Web of Science ®Google Scholar
• Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417(6890):750–4. doi:10.1038/nature00804.
   PubMed Web of Science ®Google Scholar
• Gerlis LM. The significance of adventitial infiltrations in coronary atherosclerosis. Br Heart J. 1956;18(2):166–72. doi:10.1136/hrt.18.2.166.
   PubMedGoogle Scholar
• Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–80. doi:10.1038/nrneph.2017.51.
   PubMed Web of Science ®Google Scholar
• Winkels H, Ehinger E, Vassallo M, Buscher K, Dinh HQ, Kobiyama K, Hamers A, Cochain C, Vafadarnejad E, Saliba AE, et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell rna-sequencing and mass cytometry. Circ Res. 2018;122(12):1675–88. doi:10.1161/CIRCRESAHA.117.312513.
   PubMed Web of Science ®Google Scholar
• Libby P. Collagenases and cracks in the plaque. J Clin Invest. 2013;123(8):3201–3. doi:10.1172/JCI67526.
   PubMed Web of Science ®Google Scholar
• Porsch F, Mallat Z, Binder CJ. Humoral immunity in atherosclerosis and myocardial infarction: from b cells to antibodies. Cardiovasc Res. 2021;117(13):2544–62. doi:10.1093/cvr/cvab285.
   PubMed Web of Science ®Google Scholar
• Srikakulapu P, Hu D, Yin C, Mohanta SK, Bontha SV, Peng L, Beer M, Weber C, Mcnamara CA, Grassia G, et al. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-Cell responses in aged ApoE −/− mice. ATVB. 2016;36(6):1174–85. doi:10.1161/ATVBAHA.115.306983.
   Google Scholar
• Libby P. Inflammation in atherosclerosis-no longer a theory. Clin Chem. 2021;67(1):131–42. doi:10.1093/clinchem/hvaa275.
   PubMed Web of Science ®Google Scholar
• Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105(3):1809–31. doi:10.1007/s11192-015-1645-z.
   PubMed Web of Science ®Google Scholar
• Chen CM. Citespace ii: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57(3):359–77. doi:10.1002/asi.20317.
   Web of Science ®Google Scholar
• Chen Y, Chen C, Liu Z, Gang HZ, Wang X, Lab W, Informatics, University D. The methodology function of citespace mapping knowledge domains. Stud Sci Sci. 2015;33:242–53.
   Google Scholar
• van Eck NJ, Waltman L. Software survey: vosviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38. doi:10.1007/s11192-009-0146-3.
   PubMed Web of Science ®Google Scholar
• Aria M, Cuccurullo C. Bibliometrix: an r-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959–75. doi:10.1016/j.joi.2017.08.007.
   Web of Science ®Google Scholar
• Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Bäckhed F, Miller YI, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest. 2009;119(5):1335–49. doi:10.1172/JCI36800.
   PubMed Web of Science ®Google Scholar
• Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel IP, Cano M, Brandstätter H, Tsimikas S, Skerka C, et al. Complement factor h binds malondialdehyde epitopes and protects from oxidative stress. Nature. 2011;478(7367):76–81. doi:10.1038/nature10449.
   PubMed Web of Science ®Google Scholar
• Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ. B cells and humoral immunity in atherosclerosis. Circ Res. 2014;114(11):1743–56. doi:10.1161/CIRCRESAHA.113.301145.
   PubMed Web of Science ®Google Scholar
• Tsiantoulas D, Sage AP, Mallat Z, Binder CJ. Targeting b cells in atherosclerosis: closing the gap from bench to bedside. Arterioscler Thromb Vasc Biol. 2015;35(2):296–302. doi:10.1161/ATVBAHA.114.303569.
   PubMed Web of Science ®Google Scholar
• Sage AP, Tsiantoulas D, Binder CJ, Mallat Z. The role of b cells in atherosclerosis. Nat Rev Cardiol. 2019;16(3):180–96. doi:10.1038/s41569-018-0106-9.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–25. doi:10.1038/nature10146.
   PubMed Web of Science ®Google Scholar
• Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by b cells of hypercholesterolemic mice. J Clin Invest. 2002;109(6):745–53. doi:10.1172/JCI7272.
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vré E, Esposito B, Vilar J, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med. 2010;207(8):1579–87. doi:10.1084/jem.20100155.
   PubMed Web of Science ®Google Scholar
• Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in ldl receptor-null mice. Arterioscler Thromb Vasc Biol. 2002;22(11):1892–8. doi:10.1161/01.atv.0000039169.47943.ee.
   PubMed Web of Science ®Google Scholar
• Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, et al. Conventional b2 b cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol. 2010;185(7):4410–9. doi:10.4049/jimmunol.1000033.
   PubMed Web of Science ®Google Scholar
• Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH. B1a b lymphocytes are atheroprotective by secreting natural igm that increases igm deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res. 2011;109(8):830–4. doi:10.1161/CIRCRESAHA.111.248542.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12(3):204–12. doi:10.1038/ni.2001.
   PubMed Web of Science ®Google Scholar
• Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between streptococcus pneumoniae and oxidized ldl. Nat Med. 2003;9(6):736–43. doi:10.1038/nm876.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Mechanisms of disease - inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95. doi:10.1056/NEJMra043430.
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Salomon BL, Potteaux S, Robertson A, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, et al. Natural regulatory t cells control the development of atherosclerosis in mice. Nat Med. 2006;12(2):178–80. doi:10.1038/nm1343.
   PubMed Web of Science ®Google Scholar
• Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL. Il-5 links adaptive and natural immunity specific for epitopes of oxidized ldl and protects from atherosclerosis. J Clin Invest. 2004;114(3):427–37. doi:10.1172/jci200420479.
   PubMed Web of Science ®Google Scholar
• Jones T, Huggett S, Kamalski J. Finding a way through the scientific literature: indexes and measures. World Neurosurg. 2011;76(1–2):36–8. doi:10.1016/j.wneu.2011.01.015.
   PubMed Web of Science ®Google Scholar
• Hoeffel C. Journal impact factors. Allergy. 1998;53(12):1225. doi:10.1111/j.1398-9995.1998.tb03848.x.
   PubMed Web of Science ®Google Scholar
• Kantor AB, Herzenberg LA. Origin of murine b cell lineages. Annu Rev Immunol. 1993;11:501–38. doi:10.1146/annurev.iy.11.040193.002441.
   PubMed Web of Science ®Google Scholar
• Montecino-Rodriguez E, Dorshkind K. B-1 b cell development in the fetus and adult. Immunity. 2012;36(1):13–21. doi:10.1016/j.immuni.2011.11.017.
   PubMed Web of Science ®Google Scholar
• Baumgarth N. B-1 cell heterogeneity and the regulation of natural and antigen-induced igm production. Front Immunol. 2016;7:324. doi:10.3389/fimmu.2016.00324.
   PubMed Web of Science ®Google Scholar
• Shaw PX, Hörkkö S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, Witztum JL. Natural antibodies with the t15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000;105(12):1731–40. doi:10.1172/JCI8472.
   PubMed Web of Science ®Google Scholar
• Rosenfeld SM, Perry HM, Gonen A, Prohaska TA, Srikakulapu P, Grewal S, Das D, Mcskimming C, Taylor AM, Tsimikas S, et al. B-1b cells secrete atheroprotective igm and attenuate atherosclerosis. Circ Res. 2015;117(3):e28–e39. doi:10.1161/CIRCRESAHA.117.306044.
   PubMed Web of Science ®Google Scholar
• Ghosn EE, Sadate-Ngatchou P, Yang Y, Herzenberg LA, Herzenberg LA. Distinct progenitors for b-1 and b-2 cells are present in adult mouse spleen. Proc Natl Acad Sci U S A. 2011;108(7):2879–84. doi:10.1073/pnas.1019764108.
   PubMed Web of Science ®Google Scholar
• Ghosn EE, Yamamoto R, Hamanaka S, Yang Y, Herzenberg LA, Nakauchi H, Herzenberg LA. Distinct b-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc Natl Acad Sci U S A. 2012;109(14):5394–8. doi:10.1073/pnas.1121632109.
   PubMed Web of Science ®Google Scholar
• Ma SD, Mussbacher M, Galkina EV. Functional role of b cells in atherosclerosis. Cells. 2021;10(2):270. doi:10.3390/cells10020270.
   PubMed Web of Science ®Google Scholar
• Tay C, Liu YH, Kanellakis P, Kallies A, Li Y, Cao A, Hosseini H, Tipping P, Toh BH, Bobik A, et al. Follicular B cells promote atherosclerosis via T cell–mediated differentiation into plasma cells and Secreting pathogenic immunoglobulin G. ATVB. 2018;38(5):e71–e84. doi:10.1161/ATVBAHA.117.310678.
   Google Scholar
• Nus M, Sage AP, Lu Y, Masters L, Lam B, Newland S, Weller S, Tsiantoulas D, Raffort J, Marcus D, et al. Marginal zone b cells control the response of follicular helper t cells to a high-cholesterol diet. Nat Med. 2017;23(5):601–10. doi:10.1038/nm.4315.
   PubMed Web of Science ®Google Scholar
• Tarlinton D. B-cell memory: are subsets necessary? Nat Rev Immunol. 2006;6(10):785–90. doi:10.1038/nri1938.
   PubMed Web of Science ®Google Scholar
• Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy–review of a new approach. Pharmacol Rev. 2003;55(2):241–69. doi:10.1124/pr.55.2.4.
   PubMed Web of Science ®Google Scholar
• Mauri C, Menon M. Human regulatory b cells in health and disease: therapeutic potential. J Clin Invest. 2017;127(3):772–9. doi:10.1172/JCI85113.
   PubMed Web of Science ®Google Scholar
• Shen P, Roch T, Lampropoulou V, O’Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, et al. Il-35-producing b cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507(7492):366–70. doi:10.1038/nature12979.
   PubMed Web of Science ®Google Scholar
• Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C. Lipid-antigen presentation by cd1d (+) b cells is essential for the maintenance of invariant natural killer t cells. Immunity. 2012;36(3):477–90. doi:10.1016/j.immuni.2012.02.008.
   PubMed Web of Science ®Google Scholar
• He S, Kahles F, Rattik S, Nairz M, Mcalpine CS, Anzai A, Selgrade D, Fenn AM, Chan CT, Mindur JE, et al. Gut intraepithelial t cells calibrate metabolism and accelerate cardiovascular disease. Nature. 2019;566(7742):115–19. doi:10.1038/s41586-018-0849-9.
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–27. doi:10.1161/CIRCRESAHA.118.313591.
   PubMed Web of Science ®Google Scholar
• Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145(1):33–43. doi:10.1016/s0021-9150(99)00011-8.
   PubMed Web of Science ®Google Scholar
• Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. 2020;17(7):387–401. doi:10.1038/s41569-020-0352-5.
   PubMed Web of Science ®Google Scholar
• Pinderski OL, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1999;19(12):2847–53. doi:10.1161/01.atv.19.12.2847.
   PubMed Web of Science ®Google Scholar
• Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of tgf-beta signaling in t cells accelerates atherosclerosis. J Clin Invest. 2003;112(9):1342–50. doi:10.1172/JCI18607.
   PubMed Web of Science ®Google Scholar
• Foks AC, Lichtman AH, Kuiper J. Treating atherosclerosis with regulatory t cells. Arterioscler Thromb Vasc Biol. 2015;35(2):280–7. doi:10.1161/ATVBAHA.114.303568.
   PubMed Web of Science ®Google Scholar
• Gewaltig J, Kummer M, Koella C, Cathomas G, Biedermann BC. Requirements for cd8 t-cell migration into the human arterial wall. Hum Pathol. 2008;39(12):1756–62. doi:10.1016/j.humpath.2008.04.018.
   PubMed Web of Science ®Google Scholar
• van Puijvelde GH, van Wanrooij EJ, Hauer AD, de Vos P, van Berkel TJ, Kuiper J. Effect of natural killer t cell activation on the initiation of atherosclerosis. Thromb Haemost. 2009;102(2):223–30. doi:10.1160/TH09-01-0020.
   PubMed Web of Science ®Google Scholar
• Li Y, To K, Kanellakis P, Hosseini H, Deswaerte V, Tipping P, Smyth MJ, Toh BH, Bobik A, Kyaw T. Cd4+ natural killer t cells potently augment aortic root atherosclerosis by perforin- and granzyme b-dependent cytotoxicity. Circ Res. 2015;116(2):245–54. doi:10.1161/CIRCRESAHA.116.304734.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, Macfadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31. doi:10.1056/NEJMoa1707914.
   PubMed Web of Science ®Google Scholar
• Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–505. doi:10.1056/NEJMoa1912388.
   PubMed Web of Science ®Google Scholar
• Nidorf SM, Fiolet A, Mosterd A, Eikelboom JW, Schut A, Opstal T, The S, Xu XF, Ireland MA, Lenderink T, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838–47. doi:10.1056/NEJMoa2021372.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Pradhan A, Macfadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752–62. doi:10.1056/NEJMoa1809798.
   PubMed Web of Science ®Google Scholar
• Hollan I, Meroni PL, Ahearn JM, Cohen TJ, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12(10):1004–15. doi:10.1016/j.autrev.2013.03.013.
   PubMed Web of Science ®Google Scholar
• Zeboudj L, Maitre M, Guyonnet L, Laurans L, Joffre J, Lemarie J, Bourcier S, Nour-Eldine W, Guerin C, Friard J, et al. Selective egf-receptor inhibition in cd4(+) t cells induces anergy and limits atherosclerosis. J Am Coll Cardiol. 2018;71(2):160–72. doi:10.1016/j.jacc.2017.10.084.
   PubMed Web of Science ®Google Scholar
• Mathieu S, Pereira B, Dubost JJ, Lusson JR, Soubrier M. No significant change in arterial stiffness in ra after 6 months and 1 year of rituximab treatment. Rheumatology. 2012;51(6):1107–11. doi:10.1093/rheumatology/kes006.
   PubMed Web of Science ®Google Scholar
• Abbate A, Van Tassell BW, Biondi-Zoccai G, Kontos MC, Grizzard JD, Spillman DW, Oddi C, Roberts CS, Melchior RD, Mueller GH, et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia commonwealth university-anakinra remodeling trial (2) (vcu-art2) pilot study]. Am J Cardiol. 2013;111(10):1394–400. doi:10.1016/j.amjcard.2013.01.287.
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, et al. Efficacy and safety of more intensive lowering of ldl cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81. doi:10.1016/S0140-6736(10)61350-5.
   PubMed Web of Science ®Google Scholar
• Hammersley D, Signy M. Ezetimibe: an update on its clinical usefulness in specific patient groups. Ther Adv Chronic Dis. 2017;8(1):4–11. doi:10.1177/2040622316672544.
   PubMed Web of Science ®Google Scholar
• Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El SM, et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372(16):1489–99. doi:10.1056/NEJMoa1501031.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372(16):1500–9. doi:10.1056/NEJMoa1500858.
   PubMed Web of Science ®Google Scholar
• Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33. doi:10.1038/s41586-021-03392-8.
   PubMed Web of Science ®Google Scholar
• Musunuru K, Kathiresan S. Surprises from genetic analyses of lipid risk factors for atherosclerosis. Circ Res. 2016;118(4):579–85. doi:10.1161/CIRCRESAHA.115.306398.
   PubMed Web of Science ®Google Scholar
• Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, et al. Plasma hdl cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572–80. doi:10.1016/S0140-6736(12)60312-2.
   PubMed Web of Science ®Google Scholar